» Articles » PMID: 1692625

Enzymatically Active Lysosomal Proteases Are Associated with Amyloid Deposits in Alzheimer Brain

Overview
Specialty Science
Date 1990 May 1
PMID 1692625
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The formation of beta-amyloid in the brains of individuals with Alzheimer disease requires the proteolytic cleavage of a membrane-associated precursor protein. The proteases that may be involved in this process have not yet been identified. Cathepsins are normally intracellular proteolytic enzymes associated with lysosomes; however, when sections from Alzheimer brains were stained by antisera to cathepsin D and cathepsin B, high levels of immunoreactivity were also detected in senile plaques. Extracellular sites of cathepsin immunoreactivity were not seen in control brains from age-matched individuals without neurologic disease or from patients with Huntington disease or Parkinson disease. In situ enzyme histochemistry of cathepsin D and cathepsin B on sections of neocortex using synthetic peptides and protein substrates showed that senile plaques contained the highest levels of enzymatically active cathepsin. At the ultrastructural level, cathepsin immunoreactivity in senile plaques was localized principally to lysosomal dense bodies and lipofuscin granules, which were extracellular. Similar structures were abundant in degenerating neurons of Alzheimer neocortex, and cathepsin-laden neuronal perikarya in various stages of disintegration could be seen within some senile plaques. The high levels of enzymatically competent lysosomal proteases abnormally localized in senile plaques represent evidence for candidate enzymes that may mediate the proteolytic formation of amyloid. We propose that amyloid precursor protein within senile plaques is processed by lysosomal proteases principally derived from degenerating neurons. Escape of cathepsins from the stringently regulated intracellular milieu provides a basis for an abnormal sequence of proteolytic cleavages of accumulating amyloid precursor protein.

Citing Articles

Circulating proteomic biomarkers for cerebral amyloid angiopathy screening and risk stratification.

Xu J, Su Y, Sha Y, Fu J, Yan T, Xu F Alzheimers Dement. 2025; 21(3):e70044.

PMID: 40042503 PMC: 11881623. DOI: 10.1002/alz.70044.


Cathepsin B prevents cell death by fragmentation and destruction of pathological amyloid fibrils.

Sulatsky M, Stepanenko O, Stepanenko O, Mikhailova E, Sulatskaya A Cell Death Discov. 2025; 11(1):61.

PMID: 39955315 PMC: 11830053. DOI: 10.1038/s41420-025-02343-w.


Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study.

Jiang Y, Fan W, Li Y, Xue H Brain Behav. 2024; 15(1):e70207.

PMID: 39740768 PMC: 11688054. DOI: 10.1002/brb3.70207.


Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease.

Mancano A, Pina J, Froes B, Sciani J Front Mol Biosci. 2024; 11:1490275.

PMID: 39544403 PMC: 11560772. DOI: 10.3389/fmolb.2024.1490275.


Autophagy-lysosomal-associated neuronal death in neurodegenerative disease.

Nixon R Acta Neuropathol. 2024; 148(1):42.

PMID: 39259382 PMC: 11418399. DOI: 10.1007/s00401-024-02799-7.


References
1.
Yankner B, Dawes L, Fisher S, Neve R . Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989; 245(4916):417-20. DOI: 10.1126/science.2474201. View

2.
Van Nostrand W, Wagner S, Suzuki M, Choi B, Farrow J, Geddes J . Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 1989; 341(6242):546-9. DOI: 10.1038/341546a0. View

3.
Selkoe D, Podlisny M, Joachim C, Vickers E, Lee G, Fritz L . Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988; 85(19):7341-5. PMC: 282182. DOI: 10.1073/pnas.85.19.7341. View

4.
Majocha R, Benes F, Reifel J, Rodenrys A, Marotta C . Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci U S A. 1988; 85(16):6182-6. PMC: 281929. DOI: 10.1073/pnas.85.16.6182. View

5.
Perry G, Lipphardt S, Mulvihill P, Kancherla M, Mijares M, Gambetti P . Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet. 1988; 2(8613):746. DOI: 10.1016/s0140-6736(88)90219-x. View